Want to start a fight? Step one: Offer up an estimate for what it costs to develop a new drug
There’s no better way to get a debate underway in biopharma than coming up with a hard estimate for what it costs to develop a new drug. Industry critics like Public Citizen have delighted in calling out developers for what they see as inflated numbers. Tufts came up with the most frequently cited figure: totting up at $2.6 billion. And FDA commissioner Scott Gottlieb even recently cited the high cost of drug development, tying it to high prices when he laid out a plan to help speed up R&D in the US.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.